EAM
Eventide Asset Management Portfolio holdings
AUM
$6.08B
1-Year Est. Return
64.4%
1 Year Est. Return
+64.4%
AUM
$6.08B
AUM Growth
+$375M
(+6.6%)
Holding
263
Top Buys
| 1 | +$35.1M | |
| 2 | +$33.7M | |
| 3 | +$31.6M | |
| 4 |
Amylyx Pharmaceuticals
AMLX
|
+$20.6M |
| 5 |
Evolent Health
EVH
|
+$18.7M |
Top Sells
| 1 | +$217M | |
| 2 | +$93.4M | |
| 3 | +$29.4M | |
| 4 |
Insmed
INSM
|
+$27.6M |
| 5 |
Remitly
RELY
|
+$27M |
Sector Composition
| 1 | Healthcare | 37.53% |
| 2 | Industrials | 18.58% |
| 3 | Technology | 17.54% |
| 4 | Consumer Discretionary | 8.04% |
| 5 | Utilities | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Privia Health
PRVA
$2.81B
| $18.4M | 0.3% |
737,694
-84,754
|
|
||
102
Rockwell Automation
ROK
$46.9B
| $18.1M | 0.3% |
51,819
+837
|
|
||
103
monday.com
MNDY
$6.72B
| $18M | 0.3% |
92,611
-50,720
|
|
||
104
MongoDB
MDB
$31.5B
| $17.5M | 0.29% |
56,473
+55,085
|
|
||
105
IDEAYA Biosciences
IDYA
$3.25B
| $17M | 0.28% |
625,704
-146,140
|
|
||
106
American Express
AXP
$247B
| $16.7M | 0.28% |
49,745
+9,035
|
|
||
107
Procept Biorobotics
PRCT
$1.75B
| $16.7M | 0.27% |
468,476
|
|
||
108
Xylem
XYL
$34.1B
| $16.6M | 0.27% |
112,848
+546
|
|
||
109
Public Service Enterprise Group
PEG
$39.4B
| $16.6M | 0.27% |
199,197
-29,197
|
|
||
110
Avidity Biosciences
RNA
$10.9B
| $16.4M | 0.27% |
375,989
+65
|
|
||
111
Broadcom
AVGO
$1.61T
| $16.1M | 0.26% |
48,853
-2,118
|
|
||
112
IDEX
IEX
$14.3B
| $15.7M | 0.26% |
96,382
-5,373
|
|
||
113
Syndax Pharmaceuticals
SNDX
$1.86B
| $15.2M | 0.25% |
988,486
-425,595
|
|
||
|
BLTE
114
Belite Bio
BLTE
$5.77B
| $14.5M | 0.24% |
+195,312
|
|
||
115
Regions Financial
RF
$24.7B
| $14.2M | 0.23% |
535,538
+283,386
|
|
||
116
Vaxcyte
PCVX
$6.35B
| $13.7M | 0.22% |
379,330
-468,811
|
|
||
117
Home Depot
HD
$374B
| $13.5M | 0.22% |
33,286
+4,083
|
|
||
118
Trevi Therapeutics
TRVI
$1.47B
| $12.6M | 0.21% |
1,381,324
|
|
||
|
BBOT
119
BridgeBio Oncology
BBOT
$963M
| $12.4M | 0.2% |
+1,082,362
|
|
||
120
Intuit
INTU
$158B
| $12.4M | 0.2% |
18,102
+3,306
|
|
||
121
Acadia Pharmaceuticals
ACAD
$4.54B
| $12.3M | 0.2% |
575,541
-152,896
|
|
||
122
S&P Global
SPGI
$165B
| $11.7M | 0.19% |
24,043
+3,343
|
|
||
123
Oric Pharmaceuticals
ORIC
$1.1B
| $11.4M | 0.19% |
951,507
+74
|
|
||
124
Trade Desk
TTD
$18B
| $11.4M | 0.19% |
232,477
-289,426
|
|
||
125
Linde
LIN
$205B
| $11.1M | 0.18% |
23,370
+910
|
|